Evidence map›Paper›PMID 33125576›Full record

ArticleEuropean journal of nutrition2021

Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population.

Indira Paz-Graniel, Nancy Babio, Nerea Becerra-Tomás, Estefania Toledo, Lucia Camacho-Barcia, Dolores Corella, Olga Castañer-Niño, Dora Romaguera, Jesús Vioque, Ángel M Alonso-Gómez and 44 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

54 authors at 20 institutions in 1 country.

Indira Paz-GranielDepartment of Biochemistry and Biotechnology, Human Nutrition Unit, Rovira i Virgili University, Reus, Spain.
Nancy BabioDepartment of Biochemistry and Biotechnology, Human Nutrition Unit, Rovira i Virgili University, Reus, Spain. nancy.babio@urv.cat.
Nerea Becerra-TomásDepartment of Biochemistry and Biotechnology, Human Nutrition Unit, Rovira i Virgili University, Reus, Spain.
Estefania ToledoCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Lucia Camacho-BarciaDepartment of Biochemistry and Biotechnology, Human Nutrition Unit, Rovira i Virgili University, Reus, Spain.
Dolores CorellaCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Olga Castañer-NiñoCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Dora RomagueraCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Jesús VioqueCIBER Epidemiology and Public Health (CIBERESP), Carlos III Health Institute, Madrid, Spain.
Ángel M Alonso-GómezCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Julia WärnbergCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
J Alfredo MartínezCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Luís Serra-MajemCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Ramon EstruchCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Francisco J TinahonesCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Fernando Fernandez-ArandaCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
José LapetraCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Xavier PintóCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Josep A TurCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Antonio García-RiosCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Aurora Bueno-CavanillasBioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
José J GaforioCIBER Epidemiology and Public Health (CIBERESP), Carlos III Health Institute, Madrid, Spain.
Pilar Matía-MartínDepartment of Endocrinology and Nutrition, Health Research Institute of the San Carlos Clinical Hospital (IdISSC), Madrid, Spain.
Lidia DaimielNutritional Genomics and Epigenomics Group , IMDEA Food, CEI UAM + CSIC, Madrid, Spain.
Vicente Martín SánchezCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Josep VidalCIBER Diabetes and Associated Metabolic Diseases (CIBERDEM), Carlos III Health Institute (ISCIII), Madrid, Spain.
Lucía Prieto-SanchezDepartment of Endocrinology, Fundación Jiménez-Díaz, Madrid, Spain.
Emilio RosCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Cristina RazquinCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Cristina MestresJoan XXIII University Hospital, Tarragona, Spain.
José V SorliCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Aida M Cuenca-RoyoCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Angel RiosHealth Research Institute of the Balearic Islands (IdISBa), University Hospital Son Espases, Palma, Spain.
Laura Torres-ColladoCIBER Epidemiology and Public Health (CIBERESP), Carlos III Health Institute, Madrid, Spain.
Jessica Vaquero-LunaCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Napoleon Pérez-FarinósCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
M Angeles ZuletCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Almudena Sanchez-VillegasCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Rosa CasasCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
M Rosa Bernal-LopezCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
José Manuel Santos-LozanoCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Xavier CorbellaLipids and Vascular Risk Unit, Internal Medicine, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain.
David MateosCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Pilar Buil-CosialesCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Susana Jiménez-MurciaCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Rebeca Fernandez-CarrionCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Laura Forcano-GamazoCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Meritxell LópezHealth Research Institute of the Balearic Islands (IdISBa), University Hospital Son Espases, Palma, Spain.
Miguel Ángel Sempere-PascualSanta Pola Health Center, Alicante, Spain.
Anai Moreno-RodriguezCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Alfredo GeaCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Rafael de la Torre-FornellCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain.
Jordi Salas-SalvadóDepartment of Biochemistry and Biotechnology, Human Nutrition Unit, Rovira i Virgili University, Reus, Spain. jordi.salas@urv.cat.ORCID http://orcid.org/0000-0003-2700-7459
PREDIMED-Plus Investigators
Hospital Universitari Sant Joan de Reus · ESInstituto de Salud Carlos III · ESInstituto de Investigación Biomédica de Málaga · ESUniversity of the Basque Country · ESBellvitge University Hospital · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESHospital Del Mar · ESUniversitat Internacional de Catalunya · ESMadrid Institute for Advanced Studies · ESUniversitat de València · ESUniversidad de Navarra · ESUniversidad de Las Palmas de Gran Canaria · ESUniversitat de Miguel Hernández d'Elx · ESHospital Universitario Fundación Jiménez Díaz · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESAgencia de Evaluación de Tecnologías Sanitarias · ESUniversidad de Jaén · ESUniversidad de León · ESHealth Research Institute of the Balearic Islands · ESSpanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition · ES

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca FI-DGR 2017Consejería de Salud de la Junta de Andalucía PI0137/2018Consejería de Salud de la Junta de Andalucía PI0458/2013Consejería de Salud de la Junta de Andalucía PS0358/2016Departament de Salut, Generalitat de Catalunya SLT006/17/00246EU-H2020 EAT2BENICE/H2020-SFS-2016-2; Ref 728018European Regional Development Fund () CB06/03Generalitat de Catalunya (ES) CERCA ProgrammeGeneralitat Valenciana PROMETEO/2017/017H2020 European Research Council 340918ICREA Academia programme ICREAInstituto de Salud Carlos III CP15/00028Instituto de Salud Carlos III PI13/00233Instituto de Salud Carlos III PI13/00272Instituto de Salud Carlos III PI13/00492Instituto de Salud Carlos III PI13/00673Instituto de Salud Carlos III PI13/00728Instituto de Salud Carlos III PI13/01056Instituto de Salud Carlos III PI13/01090Instituto de Salud Carlos III PI13/01123Instituto de Salud Carlos III PI13/02184Instituto de Salud Carlos III PI14/00618Instituto de Salud Carlos III PI14/00636Instituto de Salud Carlos III PI14/00696Instituto de Salud Carlos III PI14/00728Instituto de Salud Carlos III PI14/00853Instituto de Salud Carlos III PI14/00972Instituto de Salud Carlos III PI14/01206Instituto de Salud Carlos III PI14/01471Instituto de Salud Carlos III PI14/01722Instituto de Salud Carlos III PI16/00366Instituto de Salud Carlos III PI16/00381Instituto de Salud Carlos III PI16/00501Instituto de Salud Carlos III PI16/00533Instituto de Salud Carlos III PI16/00662Instituto de Salud Carlos III PI16/01094Instituto de Salud Carlos III PI16/01120Instituto de Salud Carlos III PI16/01522Instituto de Salud Carlos III PI16/01873Instituto de Salud Carlos III PI17/00215Instituto de Salud Carlos III PI17/00508Instituto de Salud Carlos III PI17/00525Instituto de Salud Carlos III PI17/00764Instituto de Salud Carlos III PI17/00855Instituto de Salud Carlos III PI17/00926Instituto de Salud Carlos III PI17/01183Instituto de Salud Carlos III PI17/01347Instituto de Salud Carlos III PI17/01441Instituto de Salud Carlos III PI17/01732Instituto de Salud Carlos III PI17/01827Instituto de Salud Carlos III PI19/00017Instituto de Salud Carlos III PI19/00309Instituto de Salud Carlos III PI19/00386Instituto de Salud Carlos III PI19/00576Instituto de Salud Carlos III PI19/00781Instituto de Salud Carlos III PI19/00957Instituto de Salud Carlos III PI19/01032Instituto de Salud Carlos III PI19/01226Instituto de Salud Carlos III PI19/01332Instituto de Salud Carlos III PI19/01560Instituto de Salud Carlos III (ES) PI13/00462Instituto de Salud Carlos III (ES) PI14/01374Instituto de Salud Carlos III (ES) PI14/01919Instituto de Salud Carlos III (ES) PI16/00473Instituto de Salud Carlos III (ES) PI17/00532Ministerio de Educación, Cultura y Deporte FPU 17/01925Recercaixa Grant 2013ACUP00194SEMERGEN grantSEMERGEN grant --Special Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-PlusSpecial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus --
6 · The paper itself

Abstract

purposeCoffee is rich in compounds such as polyphenols, caffeine, diterpenes, melanoidins and trigonelline, which can stimulate brain activity. Therefore, the possible association of coffee consumption with cognition is of considerable research interest. In this paper, we assess the association of coffee consumption and total dietary caffeine intake with the risk of poor cognitive functioning in a population of elderly overweight/obese adults with metabolic syndrome (MetS).

methodsPREDIMED-plus study participants who completed the Mini-Mental State Examination test (MMSE) (n = 6427; mean age = 65 ± 5 years) or a battery of neuropsychological tests were included in this cross-sectional analysis. Coffee consumption and total dietary caffeine intake were assessed at baseline using a food frequency questionnaire. Logistic regression models were fitted to evaluate the association between total, caffeinated and decaffeinated coffee consumption or total dietary caffeine intake and cognitive impairment.

resultsTotal coffee consumers and caffeinated coffee consumers had better cognitive functioning than non-consumers when measured by the MMSE and after adjusting for potential confounders (OR 0.63; 95% CI 0.44-0.90 and OR 0.56; 95% CI 0.38-0.83, respectively). Results were similar when cognitive performance was measured using the Clock Drawing Test (CDT) and Trail Making Test B (TMT-B). These associations were not observed for decaffeinated coffee consumption. Participants in the highest tertile of total dietary caffeine intake had lower odds of poor cognitive functioning than those in the reference tertile when screened by the MMSE (OR 0.64; 95% CI 0.47-0.87) or other neurophysiological tests evaluating a variety of cognitive domains (i.e., CDT and TMT-A).

conclusionsCoffee consumption and total dietary caffeine intake were associated with better cognitive functioning as measured by various neuropsychological tests in a Mediterranean cohort of elderly individuals with MetS.

trial registrationISRCTN89898870. Registration date: July 24, 2014.

Indexed as

CaffeineCoffeeAdultAgedCognitionCohort StudiesCross-Sectional StudiesHumansMiddle AgedRisk FactorsCaffeineCoffeeCaffeineCoffeeCognitive impairmentMini-Mental State ExaminationPREDIMED-plus

Identifiers

PMID33125576
OpenAlexW3097559918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.